• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Transformed Blasts in TP53-Mutated Leukemia Mimic Malignant Histiocytic Neoplasms

by
November 8, 2026
in Health
Reading Time: 2 mins read
0
Transformed Blasts in TP53-Mutated Leukemia Mimic Malignant Histiocytic Neoplasms

Transformed Blasts in TP53-Mutated Leukemia Mimic Malignant Histiocytic Neoplasms

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a case report published in Blood Research, researchers Neha Seth and Aishwarya Ravindran describe a significant diagnostic challenge involving acute myeloid leukemia with monocytic differentiation and a TP53 mutation. Following induction chemotherapy, the patient’s disease exhibited a striking histiocytoid morphologic transformation, altering the typical appearance of the post-treatment leukemic blast cells.

Detailed examination showed that the post-treatment myeloid-lineage blasts had undergone substantial structural changes, creating marked morphologic overlap with mature malignant histiocytic neoplasms. The investigators noted that this deceptive resemblance was particularly evident when compared against the histiocytic sarcoma subtype, leading to notable diagnostic complexity.

This pronounced morphological mimicry represented a critical diagnostic pitfall during post-treatment disease evaluation. Because the transformed leukemic blasts closely imitated mature histiocytic cells, the observed cellular changes raised the challenging question of distinguishing persistent leukemia from a divergent histiocytic malignancy.

To address this diagnostic challenge, the investigators assessed specific protein marker expressions within the post-treatment blast population. Their laboratory evaluation identified retained myeloperoxidase expression together with a complete absence of cyclin D1 expression in the transformed cells.

These immunophenotypic findings provided essential evidence to clarify the patient’s diagnosis. Retained myeloperoxidase expression, alongside the lack of cyclin D1, supported a diagnosis of persistent acute myeloid leukemia rather than divergent histiocytic differentiation, resolving the deceptive morphologic overlap.

Subject of Research: Histiocytoid morphologic transformation in TP53-mutated acute myeloid leukemia

Article Title: Myeloid-lineage blasts with histiocytoid differentiation in TP53 mutated acute myeloid leukemia: a deceptive morphologic overlap with mature malignant histiocytic neoplasms

Article References: Seth, N., & Ravindran, A. (2026). Myeloid-lineage blasts with histiocytoid differentiation in TP53 mutated acute myeloid leukemia: a deceptive morphologic overlap with mature malignant histiocytic neoplasms. Blood Research, 61(1), Article 40. https://doi.org/10.1007/s44313-026-00156-z

Image Credits: AI Generated

DOI: 10.1007/s44313-026-00156-z

Keywords: acute myeloid leukemia, TP53 mutation, histiocytoid differentiation, histiocytic neoplasms, histiocytic sarcoma, chemotherapy, myeloperoxidase, cyclin D1, Myeloid-lineage, blasts, histiocytoid, differentiation

News Source: Nathaniel Bowman. (November 8, 2026). Transformed Blasts in TP53-Mutated Leukemia Mimic Malignant Histiocytic Neoplasms. Scienmag.

Tags: acute myeloid leukemiablastschemotherapycyclin D1differentiationhistiocytic neoplasmshistiocytic sarcomahistiocytoidhistiocytoid differentiationMyeloid-lineagemyeloperoxidaseTP53 mutation
Share12Tweet7Share2ShareShareShare1

Related Posts

Evidence Synthesis Challenges Universal Antibiotic Exposure Rules for Gram-Negative Resistance

Evidence Synthesis Challenges Universal Antibiotic Exposure Rules for Gram-Negative Resistance

November 20, 2026
Qualitative Study Identifies Drivers of HPV Vaccine Acceptance Ahead of Ghana Introduction

Qualitative Study Identifies Drivers of HPV Vaccine Acceptance Ahead of Ghana Introduction

November 20, 2026

Computational Study Links miR-130b-3p and NR3C2 Pairing to Kidney Cancer Outcomes

November 20, 2026

Rat Lungworm Infection Drives Divergent Gut Microbiome and Lipid Disruptions in Rodents

November 20, 2026

POPULAR NEWS

  • Chemical and Microbial Feedback Loops Drive Soil Sickness in Medicinal Crops

    Chemical and Microbial Feedback Loops Drive Soil Sickness in Medicinal Crops

    29 shares
    Share 12 Tweet 7
  • National Survey Reveals Significant Digital Gaps Among Groups Facing Oral Health Inequities

    29 shares
    Share 12 Tweet 7
  • Review Evaluates Strategies to Prevent and Treat Mandibular Nerve Injury During Jaw Surgery

    29 shares
    Share 12 Tweet 7
  • Dental Sector Dominates Japan’s Regional Outpatient Dysphagia Rehabilitation Claims

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Evidence Synthesis Challenges Universal Antibiotic Exposure Rules for Gram-Negative Resistance

Qualitative Study Identifies Drivers of HPV Vaccine Acceptance Ahead of Ghana Introduction

Computational Study Links miR-130b-3p and NR3C2 Pairing to Kidney Cancer Outcomes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.